SCHW insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Neesha Hathi MD, Head Wealth Adv, Bnk, Tst	5,000	$97.80	46%	5.8K	Oct 1, 2026	Oct 5, 2026

What stands out

Seven insiders sold $298M with no disclosed plan: Charles Schwab ($186M), Walter Bettinger ($91.8M) and Carolyn Schwab-Pomerantz ($13.2M), plus 4 more. The filings don't state a reason.Charles Schwab: largest such sale, Jan 29, 2026 · Walter Bettinger: largest such sale, Jul 27, 2026 · Carolyn Schwab-Pomerantz: largest such sale, Aug 4, 2026

Richard Wurster bought 22K shares for $1.8M, first on May 28, 2026.Purchase, May 28, 2026

Jonathan Beatty sold 33% of vested holdings: 18K shares for $1.8M, 83% under a disclosed plan.Largest sale, Nov 12, 2025

Percentages cover 13 of 24 officers and directors. 11 are left out

Left out: Charles Schwab (most holdings were last confirmed in 2019); Walter Bettinger, Carolyn Schwab-Pomerantz, Stephen Ellis, Paul Woolway, Arun Sarin and Peter Morgan III (holdings couldn't be fully reconciled); Nigel Murtagh, Dennis Howard and Neesha Hathi (most of their shares vested during the period, so a percentage would mislead); Jonathan Craig (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

Charles Schwab

Co-Chairman, Director

Sold $186M (plan status beside the amount). Share of stake not shown: most holdings were last confirmed in 2019. Why

$186MNo plan disclosed

Walter Bettinger

Co-Chairman, Director

Sold $91.8M (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$91.8MNo plan disclosed

Jonathan Craig

MD, Head of Retail Investing

Sold $13.9M (plan status beside the amount). That is 100% of the shares held or received (after tax withholding) during the period†. A share of the starting stake is not shown: most of these shares arrived during the period. Why

$13.9M76% planned 24% no plan disclosed

Carolyn Schwab-Pomerantz

Director

Sold $13.2M (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$13.2MNo plan disclosed

Nigel Murtagh

Chief Risk Officer

Sold $11.5M (plan status beside the amount). That is 65% of the shares held or received (after tax withholding) during the period†. A share of the starting stake is not shown: most of these shares arrived during the period. Why

$11.5MDisclosed plan

All 15 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Charles Schwab Corporation CEO selling stock?

No. Richard Wurster reported no open-market sales in the past 12 months.

Why are Charles Schwab Corporation insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 11% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 89% had no disclosed plan. A trading plan schedules sales in advance.

Are any Charles Schwab Corporation insiders buying?

Yes. 1 officer or director reported 1 purchase in the past 12 months (Form 4 code P, which includes private purchases).

How much of their stake did Charles Schwab Corporation insiders sell?

About 1.8% overall. As a group they ended with more shares than they started with. These figures leave out Charles Schwab, the largest holder (most holdings were last confirmed in 2019). That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold15 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Charles Schwab Co-Chairman, Director	$186M 1.84M shares	i No percentage: most holdings were last confirmed in 2019.	No plan disclosed
Walter Bettinger Co-Chairman, Director	$91.8M 861K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed
Jonathan Craig MD, Head of Retail Investing	$13.9M 137K shares	100%† i † Most of the shares Jonathan Craig sold arrived during the period, so this is shares sold as a share of the 0 held at the start plus the 148K received, less 11K withheld by the company for taxes.	76% under a disclosed plan 24% no plan disclosed
Carolyn Schwab-Pomerantz Director	$13.2M 126K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed
Nigel Murtagh Chief Risk Officer	$11.5M 112K shares	65%† i † Most of the shares Nigel Murtagh sold arrived during the period, so this is shares sold as a share of the 61K held at the start plus the 121K received, less 9.1K withheld by the company for taxes.	Disclosed plan
Dennis Howard MD, Chief Tech, OPS & Data Off	$6.8M 68K shares	91%† i † Most of the shares Dennis Howard sold arrived during the period, so this is shares sold as a share of the 10K held at the start plus the 72K received, less 7.5K withheld by the company for taxes.	Disclosed plan
Paul Woolway MD, Chief Banking Officer	$3.7M 38K shares	i No percentage: holdings couldn't be fully reconciled.	Disclosed plan
Jonathan Beatty MD, Head of Advisor Services	$1.8M 18K shares	33%	83% under a disclosed plan 17% no plan disclosed
Peter Morgan III General Counsel	$1.5M 15K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed
Christopher Dodds Director	$1.2M 12K shares	2.6%	No plan disclosed
Neesha Hathi MD, Head Wealth Adv, Bnk, Tst	$1.2M 11K shares	66%† i † Most of the shares Neesha Hathi sold arrived during the period, so this is shares sold as a share of the 5.8K held at the start plus the 11K received, less 0 withheld by the company for taxes.	Disclosed plan
Stephen Ellis Director	$1.0M 11K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed
Paula Sneed Director	$564K 5.3K shares	4.6%	No plan disclosed
Frank Herringer Director	$228K 2.5K shares	1.1%	No plan disclosed
Arun Sarin Director	$228K 2.5K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed

The full ownership picture18 of 24 insiders fully reconciled · 24 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Charles Schwab

Most of this insider's holdings were last confirmed in 2019. Confirmed in the last three years: 94,239,726 shares. Not confirmed since: 117,216,445 shares, left out of this row. "Still held" is not shown because it would cover only the smaller, confirmed part.

Co-Chairman, Director

96.53M

−1.84M

94.24M

see note

Vesting, gifts, unvested awards and holding lines for Charles Schwab

+180Kshares vested or exercised

−585Kgifted (net of own trusts)

−15Kwithheld by the company for taxes

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	0
Trust	Common Stock	56,331,449	53,549,441
Limited Partnership	Common Stock	30,641,981	30,021,463
Spouse as Trustee	Common Stock	9,509,797	10,624,797
188 Corp	Common Stock	44,025	44,025

Additional holdings last reported May 8, 2019, not confirmed since: 117,216,445 shares. Not included in any total or percentage on this page.

L.L.C, Common Stock: 42,853,958 shares, last reported Dec 13, 2005
LLC, Common Stock: 39,350,941 shares, last reported Aug 15, 2007
Limited Partership, Common Stock: 32,609,941 shares, last reported May 8, 2019
Family Limited Partnership, Common Stock: 2,355,329 shares, last reported Aug 15, 2007
Spouse, Common Stock: 46,276 shares, last reported Aug 4, 2015

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
104,767	$66.47	Mar 1, 2034	$3.3M
91,200	$78.12	Mar 3, 2035	$1.8M
72,489	$95.49	Mar 2, 2036	$168K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Reconciliation: minor difference of -64,950 shares. Difference is under 0.5% of holdings.

Walter Bettinger

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -764,610.022 shares on Mar 1, 2026 (Direct). See the filing Sales and other transactions for Walter Bettinger are complete.

Co-Chairman, Director

n/a

−861K

n/a

Vesting, gifts, unvested awards and holding lines for Walter Bettinger

+861Kshares vested or exercised

−61Kgifted (net of own trusts)

−61Kwithheld by the company for taxes

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -764,610.022 shares on Mar 1, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	764,610	81,014
Family Trust	Common Stock	590,734	610,360
ESOP	Common Stock	6,607	6,729
ESPP	Common Stock	4,073	4,334
Spouse	Common Stock	2,373	2,410
Spouse, as Trustee	Common Stock	176	176

Additional holdings last reported Nov 7, 2017, not confirmed since: 72,510 shares. Not included in any total or percentage on this page.

Direct, Depositary Shares: 72,510 shares, last reported Nov 7, 2017

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
154,589	$46.81	Mar 1, 2029	$7.9M
382,400	$66.47	Mar 1, 2034	$12.0M
52,440	$78.12	Mar 3, 2035	$1.0M
42,113	$95.49	Mar 2, 2036	$97K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Todd Ricketts

Director

830K

no sales

Vesting, gifts, unvested awards and holding lines for Todd Ricketts

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	379,767	379,767
Spouse as Trustee	Common Stock	295,320	295,320
Spouse	Common Stock	155,367	155,367

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Christopher Dodds

Minor difference of 1,248 shares. Difference is under 0.5% of holdings. New Form 3 filed 2014-10-28; earlier filings set aside.

Director

453K

−12K

456K

+0.6%

Vesting, gifts, unvested awards and holding lines for Christopher Dodds

+12Kshares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

New Form 3 filed 2014-10-28; earlier filings set aside.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	10,666	5,669
Trust	Common Stock	442,807	450,654

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,732	$51.97	May 22, 2033	$125K
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Reconciliation: minor difference of 1,248 shares. Difference is under 0.5% of holdings.

Carolyn Schwab-Pomerantz

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +1,396,458.6599 shares on May 26, 2026 (Trust). See the filing Sales and other transactions for Carolyn Schwab-Pomerantz are complete.

Director

n/a

−126K

n/a

Vesting, gifts, unvested awards and holding lines for Carolyn Schwab-Pomerantz

+9.9Kshares vested or exercised

−569gifted (net of own trusts)

none reportedunvested awards, start → end

An owner entity could not be identified from the footnotes.

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +1,396,458.6599 shares on May 26, 2026 (Trust). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	9,624	11,226
Trust	Common Stock	440,914	436,149
LLC	Common Stock	2,798	2,798

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Frank Herringer

Director

233K

−2.5K

240K

+3%

Vesting, gifts, unvested awards and holding lines for Frank Herringer

+7.9Kshares vested or exercised

0gifted (net of own trusts)

596K → 1.20Munvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	10,666	12,268
Trust	Common Stock	172,162	177,508
Spouse, IRA	Common Stock	50,625	50,625

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,247	$69.10	Jan 2, 2034	$64K
1,858	$72.37	Apr 1, 2034	$47K
4,496	$70.79	May 28, 2034	$121K
2,244	$73.42	Jul 1, 2034	$55K
2,621	$63.91	Oct 1, 2034	$89K
1,132	$73.84	Jan 2, 2035	$27K
1,078	$77.67	Apr 1, 2035	$22K
3,646	$88.63	May 27, 2035	$33K
909	$91.17	Jul 1, 2035	$6K
921	$92.25	Oct 1, 2035	$5K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Richard Wurster

Minor difference of 261 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed.

President & CEO, Director

162K

223K

no sales

Vesting, gifts, unvested awards and holding lines for Richard Wurster

0shares vested or exercised

0gifted (net of own trusts)

−23Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	157,189	218,409
ESPP	Common Stock	4,334	4,595

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
167,628	$66.47	Mar 1, 2034	$5.3M
231,419	$78.12	Mar 3, 2035	$4.6M
230,411	$95.49	Mar 2, 2036	$533K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Reconciliation: minor difference of 261 shares. Difference is under 0.5% of holdings.

Paula Sneed

Director

114K

−5.3K

101K

89%

Vesting, gifts, unvested awards and holding lines for Paula Sneed

0shares vested or exercised

−8.7Kgifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	8,073	9,675
Trust	Common Stock	105,654	91,711

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Stephen Ellis

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +9,765 shares on Mar 24, 2026 (Trust). See the filing Sales and other transactions for Stephen Ellis are complete.

Director

n/a

−11K

n/a

Vesting, gifts, unvested awards and holding lines for Stephen Ellis

+16Kshares vested or exercised

0gifted (net of own trusts)

46K → 98Kunvested awards, start → end

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +9,765 shares on Mar 24, 2026 (Trust). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	6,660	7,445
Trust	Common Stock	95,760	104,210

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,839	$69.10	Jan 2, 2034	$53K
1,520	$72.37	Apr 1, 2034	$39K
4,496	$70.79	May 28, 2034	$121K
3,672	$73.42	Jul 1, 2034	$90K
2,145	$63.91	Oct 1, 2034	$73K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Nigel Murtagh

Minor difference of 253 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed.

Chief Risk Officer

61K

−112K

61K

not meaningful

Vesting, gifts, unvested awards and holding lines for Nigel Murtagh

+105Kshares vested or exercised

−1Kgifted (net of own trusts)

−9.1Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	58,999	57,972
ESPP	Common Stock	2,374	2,621

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
15,675	$46.81	Mar 1, 2029	$799K
44,003	$66.47	Mar 1, 2034	$1.4M
39,216	$78.12	Mar 3, 2035	$772K
30,377	$95.49	Mar 2, 2036	$70K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Reconciliation: minor difference of 253 shares. Difference is under 0.5% of holdings.

Jonathan Beatty

MD, Head of Advisor Services

55K

−18K

43K

78%

Vesting, gifts, unvested awards and holding lines for Jonathan Beatty

+7.1Kshares vested or exercised

0gifted (net of own trusts)

−1Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	43,340	32,459
Trust	Common Stock	11,923	10,738

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
55	$63.16	Dec 1, 2033	$2K
30,096	$78.12	Mar 3, 2035	$592K
24,509	$95.49	Mar 2, 2036	$57K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Michael Verdeschi

CFO

54K

47K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Verdeschi

0shares vested or exercised

0gifted (net of own trusts)

−6.5Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	53,961	47,442

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
79,344	$78.12	Mar 3, 2035	$1.6M
62,134	$95.49	Mar 2, 2036	$144K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

John Adams Jr.

Minor difference of 442 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

49K

51K

no sales

Vesting, gifts, unvested awards and holding lines for John Adams Jr.

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	48,667	50,711

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Reconciliation: minor difference of 442 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Paul Woolway

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +30,308.4372 shares on Apr 14, 2026 (ESPP). See the filing Sales and other transactions for Paul Woolway are complete.

MD, Chief Banking Officer

n/a

−38K

n/a

Vesting, gifts, unvested awards and holding lines for Paul Woolway

+32Kshares vested or exercised

−4.1Kgifted (net of own trusts)

−2Kwithheld by the company for taxes

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +30,308.4372 shares on Apr 14, 2026 (ESPP). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	25,153	25,153
ESPP	Common Stock	7,468	7,500
Son 1	Common Stock	1,139	1,537
Son 2	Common Stock	1,139	1,537

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,131	$46.81	Mar 1, 2029	$517K
25,433	$64.10	Mar 1, 2031	$857K
17,890	$77.86	Mar 1, 2032	$357K
19,152	$77.41	Mar 1, 2033	$391K
22,002	$66.47	Mar 1, 2034	$689K
20,064	$78.12	Mar 3, 2035	$395K
15,189	$95.49	Mar 2, 2036	$35K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Charles Ruffel

Minor difference of 206 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

31K

25K

no sales

Vesting, gifts, unvested awards and holding lines for Charles Ruffel

0shares vested or exercised

−8.4Kgifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	18,110	11,381
IRA	Common Stock	9,635	9,757
401(k)	Common Stock	3,484	3,528

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,634	$69.10	Jan 2, 2034	$47K
1,351	$72.37	Apr 1, 2034	$34K
4,496	$70.79	May 28, 2034	$121K
1,632	$73.42	Jul 1, 2034	$40K
1,906	$63.91	Oct 1, 2034	$65K
1,646	$73.84	Jan 2, 2035	$39K
1,567	$77.67	Apr 1, 2035	$32K
3,646	$88.63	May 27, 2035	$33K
1,322	$91.17	Jul 1, 2035	$9K
1,340	$92.25	Oct 1, 2035	$7K
1,317	$101.57	Jan 2, 2036	$0
1,286	$92.36	Apr 1, 2036	$7K
3,977	$89.40	May 26, 2036	$33K
1,280	$95.78	Jul 1, 2036	$3K
1,222	$98.37	Oct 1, 2036	$0

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Reconciliation: minor difference of 206 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Arun Sarin

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +10,666 shares on May 26, 2026 (Direct). See the filing Sales and other transactions for Arun Sarin are complete.

Director

n/a

−2.5K

n/a

Vesting, gifts, unvested awards and holding lines for Arun Sarin

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +10,666 shares on May 26, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	10,666	12,268
Trust	Common Stock	18,617	23,983

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Joan Dea

Includes unvested RSUs, amount not disclosed.

Director

28K

no sales

Vesting, gifts, unvested awards and holding lines for Joan Dea

0shares vested or exercised

−835gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	27,673	28,440

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Marianne Brown

Director

16K

17K

no sales

Vesting, gifts, unvested awards and holding lines for Marianne Brown

0shares vested or exercised

0gifted (net of own trusts)

42K → 74Kunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	15,751	17,353

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K
3,977	$89.40	May 26, 2036	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Gerri Martin-Flickinger

Director

14K

no sales

Vesting, gifts, unvested awards and holding lines for Gerri Martin-Flickinger

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	5,767	5,767
Trust	Common Stock	8,455	8,455

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,496	$70.79	May 28, 2034	$121K
3,646	$88.63	May 27, 2035	$33K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Dennis Howard

Started reporting during the period; starting holdings are from the Form 3.

MD, Chief Tech, OPS & Data Off

10K

−68K

not meaningful

Vesting, gifts, unvested awards and holding lines for Dennis Howard

+56Kshares vested or exercised

0gifted (net of own trusts)

−7.5Kwithheld by the company for taxes

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	10,470	6,980

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
56,000	$64.10	Mar 1, 2031	$1.9M
35,779	$77.86	Mar 1, 2032	$713K
38,304	$77.41	Mar 1, 2033	$781K
44,003	$66.47	Mar 1, 2034	$1.4M
54,720	$78.12	Mar 3, 2035	$1.1M
42,458	$95.49	Mar 2, 2036	$98K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Neesha Hathi

Started reporting during the period; starting holdings are from the Form 3.

MD, Head Wealth Adv, Bnk, Tst

5.8K

−11K

5.8K

not meaningful

Vesting, gifts, unvested awards and holding lines for Neesha Hathi

+11Kshares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	0
Trust	Common Stock	5,770	5,770

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,130	$46.81	Mar 1, 2029	$517K
13,950	$41.98	Mar 2, 2030	$779K
73,246	$64.10	Mar 1, 2031	$2.5M
26,834	$77.86	Mar 1, 2032	$535K
28,272	$77.41	Mar 1, 2033	$577K
32,478	$66.47	Mar 1, 2034	$1.0M
30,096	$78.12	Mar 3, 2035	$592K
23,818	$95.49	Mar 2, 2036	$55K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Tyler Woulfe

Started reporting during the period; starting holdings are from the Form 3.

MD, Chief Banking Officer

no sales

Vesting, gifts, unvested awards and holding lines for Tyler Woulfe

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	4,018	4,018

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
9,666	$95.49	Mar 2, 2036	$22K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Peter Morgan III

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +148 shares on Jul 23, 2026 (ESPP). See the filing Sales and other transactions for Peter Morgan III are complete.

General Counsel

n/a

−15K

n/a

Vesting, gifts, unvested awards and holding lines for Peter Morgan III

+7.6Kshares vested or exercised

0gifted (net of own trusts)

−4.3Kwithheld by the company for taxes

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +148 shares on Jul 23, 2026 (ESPP). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	0
ESPP	Common Stock	451	697
ESOP	Common Stock	150	152

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
22,788	$66.47	Mar 1, 2034	$714K
27,360	$78.12	Mar 3, 2035	$538K
21,057	$95.49	Mar 2, 2036	$49K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Jonathan Craig

MD, Head of Retail Investing

−137K

not meaningful

Vesting, gifts, unvested awards and holding lines for Jonathan Craig

+122Kshares vested or exercised

0gifted (net of own trusts)

−11Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	0
Trust	Common Stock	0	0

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
69,147	$66.47	Mar 1, 2034	$2.2M
63,840	$78.12	Mar 3, 2035	$1.3M
50,052	$95.49	Mar 2, 2036	$116K

Estimate: options held × ($97.80 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

18 of 24 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (12 exactly, 6 with a minor or footnoted difference). For 6 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 13 of 24 officers and directors. Left out: Charles Schwab (most holdings were last confirmed in 2019); Walter Bettinger, Carolyn Schwab-Pomerantz, Stephen Ellis, Paul Woolway, Arun Sarin and Peter Morgan III (holdings couldn't be fully reconciled); Nigel Murtagh, Dennis Howard and Neesha Hathi (most of their shares vested during the period, so a percentage would mislead); Jonathan Craig (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$335M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $335M across 3,260,410 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $35.2M · 11%

89%

The lighter segment is sales with no plan disclosed in the filing ($299M), including tax-related sales outside a plan.

No plan disclosed · $299M

Sales with no 10b5-1 plan and no tax reference in the filing. $186M of it is Charles Schwab. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Walter Bettinger, Jul 27, 2026

Taxes

140,558 shares ($13.3M) were withheld by the company for taxes, which isn't a market sale.

Purchases · 1 buyer (1 trade)

1 officer or director bought shares in this period, in 1 trade(Form 4 code P). Across all their filings on record there are 32 purchase trades.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Charles Schwab Co-Chairman, Director	1.84M	$186M	0%	56%	Oct 28, 2025 to Aug 24, 2026
Walter Bettinger Co-Chairman, Director	861K	$91.8M	0%	27%	Feb 3, 2026 to Aug 28, 2026
Jonathan Craig MD, Head of Retail Investing	137K	$13.9M	76%	4%	Nov 7, 2025 to Aug 14, 2026
Carolyn Schwab-Pomerantz Director	126K	$13.2M	0%	4%	Jan 22, 2026 to Aug 26, 2026
Nigel Murtagh Chief Risk Officer	112K	$11.5M	100%	3%	Mar 3, 2026 to Aug 10, 2026
Dennis Howard MD, Chief Tech, OPS & Data Off	68K	$6.8M	100%	2%	Feb 25, 2026 to Aug 13, 2026
Paul Woolway MD, Chief Banking Officer	38K	$3.7M	100%	1%	Mar 2, 2026 to Apr 15, 2026
Jonathan Beatty MD, Head of Advisor Services	18K	$1.8M	83%	0.5%	Nov 12, 2025 to Aug 17, 2026
Peter Morgan III General Counsel	15K	$1.5M	0%	0.4%	Feb 2, 2026 to Jul 23, 2026
Christopher Dodds Director	12K	$1.2M	0%	0.4%	Feb 6, 2026 to Feb 6, 2026
Neesha Hathi MD, Head Wealth Adv, Bnk, Tst	11K	$1.2M	100%	0.4%	Aug 28, 2026 to Oct 1, 2026
Stephen Ellis Director	11K	$1.0M	0%	0.3%	Feb 26, 2026 to Feb 26, 2026
Paula Sneed Director	5.3K	$564K	0%	0.2%	Aug 7, 2026 to Aug 7, 2026
Frank Herringer Director	2.5K	$228K	0%	0.1%	Apr 28, 2026 to Apr 28, 2026
Arun Sarin Director	2.5K	$228K	0%	0.1%	May 13, 2026 to May 13, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$10.3M	$0	$0	$10.3M
Nov 2025	$3.7M	$301K	$0	$3.4M
Dec 2025	$204K	$204K	$0	$0
Jan 2026	$41.0M	$210K	$0	$40.8M
Feb 2026	$73.7M	$2.7M	$0	$71.0M
Mar 2026	$5.1M	$5.1M	$0	$0
Apr 2026	$25.0M	$7.8M	$0	$17.2M
May 2026	$31.3M	$0	$0	$31.3M
Jun 2026	$0	$0	$0	$0
Jul 2026	$62.5M	$9.8M	$0	$52.7M
Aug 2026	$81.0M	$8.2M	$0	$72.7M
Sep 2026	$346K	$346K	$0	$0
Oct 2026	$489K	$489K	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 15 insiders sold; the average is 13 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	3.26M	15	$335M
Oct 9, 2025 1 year earlier	2.95M	14	$255M
Oct 9, 2024 2 years earlier	1.25M	16	$88.4M
Oct 10, 2023 3 years earlier	1.67M	9	$128M
Oct 10, 2022 4 years earlier	3.54M	11	$285M
Oct 10, 2021 5 years earlier	6.87M	14	$421M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty6 insiders whose holdings couldn't be fully reconciled

Walter Bettinger: holdings couldn't be fully reconciled (difference of -683,176 shares). Balance changed without a matching transaction, and the footnote does not state the amount: -764,610.022 shares on Mar 1, 2026 (Direct). Filing, Mar 1, 2026

Footnote: "Shares acquired on the vesting of performance-based restricted stock units ("PBRSUs") granted under the company's 2022 Stock Incentive Plan, reflecting the achievement by the reporting person of the performance goal over a three-year performance period ended December 31, 2025."

Carolyn Schwab-Pomerantz: holdings couldn't be fully reconciled (difference of 111,695 shares). Balance changed with no matching transaction and no footnote: +1,396,458.6599 shares on May 26, 2026 (Trust). Filing, May 26, 2026

Stephen Ellis: holdings couldn't be fully reconciled (difference of 2,496 shares). A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +9,765 shares on Mar 24, 2026 (Trust). Filing, Mar 24, 2026

Footnote: "Reflects the contribution of shares received upon exercise of the option to a revocable trust."

Paul Woolway: holdings couldn't be fully reconciled (difference of 4,944 shares). A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +30,308.4372 shares on Apr 14, 2026 (ESPP). Filing, Apr 14, 2026

Footnote: "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2025. | This transaction was executed in multiple trades at prices ranging from $98.00 to $98.025. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Reflects the contribution of the shares received upon exercise of the option t"

Arun Sarin: holdings couldn't be fully reconciled (difference of 7,866 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +10,666 shares on May 26, 2026 (Direct). Filing, May 26, 2026

Footnote: "The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date."

Peter Morgan III: holdings couldn't be fully reconciled (difference of 248 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +148 shares on Jul 23, 2026 (ESPP). Filing, Jul 23, 2026

Footnote: "This information is based on a plan statement as of July 15, 2026."

Charles Schwab: minor difference of -64,950 shares. Difference is under 0.5% of holdings.

Christopher Dodds: minor difference of 1,248 shares. Difference is under 0.5% of holdings.

Richard Wurster: minor difference of 261 shares. Difference is under 0.5% of holdings.

Nigel Murtagh: minor difference of 253 shares. Difference is under 0.5% of holdings.

John Adams Jr.: minor difference of 442 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Charles Ruffel: minor difference of 206 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Inferred rename: "Spouse" is treated as the same holder as "Spouse, IRA", because the old name was never reported again and the new one opened with the same balance (50,625 shares). Old name, new name

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology2,595 filings from SEC EDGAR, and how we read them

All 2,595 Forms 3, 4 and 5 filed for Charles Schwab Corporation (SEC CIK 316709) from Sep 23, 2002 to Oct 5, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages. 8 filings were left out because Charles Schwab Corporation filed them as an owner of another company's stock. 64 older filings exist only on paper and could not be read.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (47)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Bharat Masrani	Jan 6, 2025	7,279 shares, last reported balance as of May 28, 2024
Bernard Clark	Jun 14, 2024	126,079 shares, last reported balance as of Jun 12, 2024
Brian Levitt	May 30, 2024	29,125 shares, last reported balance as of May 28, 2024
Peter Crawford	Apr 26, 2024	60,567 shares, last reported balance as of Apr 24, 2024
Joseph Martinetto	Apr 22, 2024	288,520 shares, last reported balance as of Apr 18, 2024
Mark Goldfarb	Apr 18, 2024	29,162 shares, last reported balance as of Apr 16, 2024
William Haraf	May 23, 2022	34,555 shares, last reported balance as of May 19, 2022
Roger Walther	Nov 19, 2020	266,481 shares, last reported balance as of Nov 18, 2020
Stephen McLin	Apr 21, 2020	164,406 shares, last reported balance as of Apr 21, 2020
Terri Kallsen	Mar 7, 2019	2,109 shares, last reported balance as of Mar 6, 2019
David Garfield	Mar 5, 2019	29,044 shares, last reported balance as of Mar 1, 2019
Marie Chandoha	Mar 5, 2019	17,777 shares, last reported balance as of Mar 5, 2019
Robert Wilson	Dec 14, 2018	194,582 shares, last reported balance as of Dec 13, 2018
Preston Butcher	May 9, 2018	945,688 shares, last reported balance as of May 8, 2018
Nancy Bechtle	Aug 7, 2017	194,100 shares, last reported balance as of Aug 7, 2017
Jay Allen	Jun 12, 2015	9,713 shares, last reported balance as of Jun 11, 2015
James McCool	Jun 9, 2015	145,590 shares, last reported balance as of Jun 5, 2015
John Clendening	Nov 5, 2014	76,472 shares, last reported balance as of Nov 3, 2014
George Gill	Nov 5, 2014	63,009 shares, last reported balance as of Nov 3, 2014
Jeffrey Brown	Apr 28, 2014	28,799 shares, last reported balance as of Apr 23, 2014
Carrie Dwyer	Apr 18, 2014	105,625 shares, last reported balance as of Apr 17, 2014
Benjamin Brigeman	Feb 6, 2012	97,609 shares, last reported balance as of Feb 3, 2012
Rebecca Saeger	Jan 24, 2011	75,889 shares, last reported balance as of Nov 2, 2010
Donald Fisher	May 20, 2009	3,602,128 shares, last reported balance as of May 18, 2009
William Aldinger III	May 20, 2009	15,898 shares, last reported balance as of May 18, 2009
Charles Goldman	Nov 24, 2008	50,024 shares, last reported balance as of Nov 17, 2008
Marjorie Magner	May 21, 2008	9,436 shares, last reported balance as of May 19, 2008
Gideon Sasson	Jun 19, 2007	192,889 shares, last reported balance as of Jun 15, 2007
David Yoffie	May 10, 2007	21,432 shares, last reported balance as of May 9, 2007
Deborah McWhinney	May 3, 2007	146,461 shares, last reported balance as of May 3, 2007
Randall Merk	Mar 6, 2007	211,740 shares, last reported balance as of Mar 6, 2007
Jan Hier-King	Feb 27, 2007	112,571 shares, last reported balance as of Feb 25, 2007
Peter Scaturro	Nov 1, 2006	203,545 shares, last reported balance as of Oct 30, 2006
William Atwell	Sep 9, 2005	No balance on record
George Shultz	Jan 21, 2005	107,775 shares, last reported balance as of Jan 19, 2005
Jeremiah Chafkin	Jan 7, 2005	105,034 shares, last reported balance as of Jan 1, 2005
Jeffrey Lyons	Dec 17, 2004	773,854 shares, last reported balance as of Dec 16, 2004
Jody Bilney	Oct 4, 2004	No balance on record
Alan Weber	Oct 4, 2004	No balance on record
Anthony Frank	Jul 6, 2004	613,533 shares, last reported balance as of May 10, 2004
David Pottruck	Apr 19, 2004	4,303,459 shares, last reported balance as of Apr 16, 2004
Mary McLeod	Feb 26, 2004	268,882 shares, last reported balance as of Feb 25, 2004
Geoffrey Penney	Feb 26, 2004	355,499 shares, last reported balance as of Feb 26, 2004
Daniel Leemon	Dec 5, 2003	267,190 shares, last reported balance as of Dec 3, 2003
Lon Gorman	Oct 16, 2003	174,334 shares, last reported balance as of Oct 15, 2003
John Coghlan	Jul 29, 2003	838,708 shares, last reported balance as of Jul 25, 2003
Dawn Lepore		No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Charles Schwab Corporation insiders sold $335M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Charles Schwab Corporation CEO selling stock?

Why are Charles Schwab Corporation insiders selling?

Are any Charles Schwab Corporation insiders buying?

How much of their stake did Charles Schwab Corporation insiders sell?

The evidence

No plan disclosed · $299M

Taxes

Purchases · 1 buyer (1 trade)

Sales by month